These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30785828)

  • 1. Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study.
    Bae JM; Chung KY; Yun SJ; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Kim M
    J Clin Oncol; 2019 Apr; 37(11):903-911. PubMed ID: 30785828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea.
    Kim HS; Kim HJ; Hong ES; Kim KB; Lee JD; Kang TU; Ahn HS
    Br J Dermatol; 2020 Apr; 182(4):907-915. PubMed ID: 31233609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced risk of skin cancer and internal malignancies in vitiligo patients: a retrospective population-based cohort study in Taiwan.
    Weng YC; Ho HJ; Chang YL; Chang YT; Wu CY; Chen YJ
    Sci Rep; 2021 Oct; 11(1):20195. PubMed ID: 34642421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy.
    Bae JM; Ju HJ; Lee RW; Oh SH; Shin JH; Kang HY; Park JH; Kim HJ; Jeong KH; Lee HJ; Lee S; Kim DH; Lee DY; Kim YC; Choi GS; Kim KH; Park CJ; Choi CW;
    JAMA Dermatol; 2020 May; 156(5):529-537. PubMed ID: 32159729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population-based cohort study.
    Yun SJ; Bae JM; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Chung KY
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):746-753. PubMed ID: 31494979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.
    Paradisi A; Tabolli S; Didona B; Sobrino L; Russo N; Abeni D
    J Am Acad Dermatol; 2014 Dec; 71(6):1110-6. PubMed ID: 25242557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markedly increased risk of malignancies in women with endometriosis.
    Eoh KJ; Han M; Kim EH; Jung I; Kim YT
    Gynecol Oncol; 2021 Apr; 161(1):291-296. PubMed ID: 33514482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea.
    Bae JM; Lee JH; Yun JS; Han B; Han TY
    J Am Acad Dermatol; 2017 May; 76(5):871-878. PubMed ID: 28238453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Melanoma and Nonmelanoma Skin Cancer in People with Vitiligo: United Kingdom Population-Based Cohort Study.
    Ferguson J; Eleftheriadou V; Nesnas J
    J Invest Dermatol; 2023 Nov; 143(11):2204-2210. PubMed ID: 37146674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to 'The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea'.
    Choi JW; Lee ES
    Br J Dermatol; 2020 Dec; 183(6):1149-1150. PubMed ID: 32762038
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to 'The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea' - reply from the authors.
    Kim HS; Ahn HS
    Br J Dermatol; 2020 Dec; 183(6):1150-1151. PubMed ID: 32767749
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of vitiligo and associated comorbidities in Korea.
    Lee H; Lee MH; Lee DY; Kang HY; Kim KH; Choi GS; Shin J; Lee HJ; Kim DH; Kim TH; Lee AY; Lee SC; Lee S; Kim KW; Hann SK; Park CJ; Oh SH
    Yonsei Med J; 2015 May; 56(3):719-25. PubMed ID: 25837178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Risk of Vitiligo Following Anti-Tumor Necrosis Factor Therapy: A 10-Year Population-Based Cohort Study.
    Bae JM; Kim M; Lee HH; Kim KJ; Shin H; Ju HJ; Kim GM; Park CJ; Park HJ
    J Invest Dermatol; 2018 Apr; 138(4):768-774. PubMed ID: 29175284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of vitiligo in patients with SARS-CoV-2 vaccination or infection: a nationwide cohort study.
    Kim JS; Jeong CY; Lee GJ; Yeom SW; Nam KH
    Eur J Dermatol; 2024 Apr; 34(2):150-157. PubMed ID: 38907545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.
    Teulings HE; Overkamp M; Ceylan E; Nieuweboer-Krobotova L; Bos JD; Nijsten T; Wolkerstorfer AW; Luiten RM; van der Veen JP
    Br J Dermatol; 2013 Jan; 168(1):162-71. PubMed ID: 23136900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Overall and Specific Cancer Risks in Patients With Hidradenitis Suppurativa.
    Jung JM; Lee KH; Kim YJ; Chang SE; Lee MW; Choi JH; Won CH; Lee WJ
    JAMA Dermatol; 2020 Aug; 156(8):844-853. PubMed ID: 32459291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes Zoster and Subsequent Cancer Risk: A Nationwide Population-Based Cohort Study in Korea.
    Kim M; Han K; Yoo SA; Lee JH
    Dermatology; 2021; 237(1):73-78. PubMed ID: 32114571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subsequent vitiligo after hematopoietic stem cell transplantation: A nationwide population-based cohort study from Korea.
    Bae JM; Choi KH; Jung HM; Kim SY; Kim M; Kim GM; Yu DS; Lee YB
    J Am Acad Dermatol; 2017 Mar; 76(3):459-463. PubMed ID: 27836331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan.
    Chen YT; Chen YJ; Hwang CY; Lin MW; Chen TJ; Chen CC; Chu SY; Lee DD; Chang YT; Liu HN
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1362-9. PubMed ID: 25510261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of comorbid rheumatic disorders in vitiligo patients: A nationwide population-based study.
    Choi CW; Eun SH; Choi KH; Bae JM
    J Dermatol; 2017 Aug; 44(8):909-913. PubMed ID: 28370282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.